Biotech spotlight: Twist Bioscience aims to remove limits on drug discovery with DNA synthesis platform
PharmaVoice
JUNE 30, 2022
As ‘the Amazon of DNA,’ Twist CSO, Aaron Sato, discusses the company’s breakthrough approach to DNA production and its expansion into drug development.
Let's personalize your content